AQST logo

Aquestive Therapeutics (AQST) Current Liabilities

Annual Current Liabilities

$18.31 M
-$21.22 M-53.68%

December 31, 2023


Summary


Performance

AQST Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAQSTbalance sheetmetrics:

Quarterly Current Liabilities

$15.15 M
+$1.26 M+9.05%

September 30, 2024


Summary


Performance

AQST Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAQSTbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

AQST Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-53.7%-37.0%
3 y3 years-13.3%-37.0%
5 y5 years-44.4%-37.0%

AQST Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-53.7%at low-62.5%+9.1%
5 y5-year-53.7%at low-62.5%+9.1%
alltimeall time-53.7%+69.4%-62.5%+9.1%

Aquestive Therapeutics Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$15.15 M(+9.0%)
Jun 2024
-
$13.89 M(-23.1%)
Mar 2024
-
$18.06 M(-1.4%)
Dec 2023
$18.31 M(-53.7%)
$18.31 M(-23.9%)
Sep 2023
-
$24.06 M(-37.8%)
Jun 2023
-
$38.65 M(-4.3%)
Mar 2023
-
$40.38 M(+2.2%)
Dec 2022
$39.53 M(+80.0%)
$39.53 M(+8.1%)
Sep 2022
-
$36.56 M(+23.4%)
Jun 2022
-
$29.64 M(+22.5%)
Mar 2022
-
$24.18 M(+10.1%)
Dec 2021
$21.96 M
$21.96 M(-12.3%)
Sep 2021
-
$25.04 M(+8.7%)
Jun 2021
-
$23.04 M(+14.9%)
DateAnnualQuarterly
Mar 2021
-
$20.05 M(-5.0%)
Dec 2020
$21.10 M(+13.7%)
$21.10 M(+14.9%)
Sep 2020
-
$18.37 M(+23.5%)
Jun 2020
-
$14.88 M(-3.1%)
Mar 2020
-
$15.36 M(-17.2%)
Dec 2019
$18.55 M(-43.7%)
$18.55 M(-7.5%)
Sep 2019
-
$20.05 M(-18.6%)
Jun 2019
-
$24.63 M(-16.9%)
Mar 2019
-
$29.64 M(-10.1%)
Dec 2018
$32.95 M(+114.7%)
$32.95 M(+54.5%)
Sep 2018
-
$21.33 M(-9.1%)
Jun 2018
-
$23.47 M(+0.0%)
Mar 2018
-
$23.47 M(+52.9%)
Dec 2017
$15.35 M(+42.1%)
$15.35 M
Dec 2016
$10.81 M
-

FAQ

  • What is Aquestive Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Aquestive Therapeutics?
  • What is Aquestive Therapeutics annual current liabilities year-on-year change?
  • What is Aquestive Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Aquestive Therapeutics?
  • What is Aquestive Therapeutics quarterly current liabilities year-on-year change?

What is Aquestive Therapeutics annual total current liabilities?

The current annual current liabilities of AQST is $18.31 M

What is the all time high annual current liabilities for Aquestive Therapeutics?

Aquestive Therapeutics all-time high annual total current liabilities is $39.53 M

What is Aquestive Therapeutics annual current liabilities year-on-year change?

Over the past year, AQST annual total current liabilities has changed by -$21.22 M (-53.68%)

What is Aquestive Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of AQST is $15.15 M

What is the all time high quarterly current liabilities for Aquestive Therapeutics?

Aquestive Therapeutics all-time high quarterly total current liabilities is $40.38 M

What is Aquestive Therapeutics quarterly current liabilities year-on-year change?

Over the past year, AQST quarterly total current liabilities has changed by -$8.90 M (-37.02%)